Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. The adverse drug event that almost took my life

The adverse drug event that almost took my life

Participate in Research Oct 18, 2024 3 minutes

"I say yes to participate in research because it can prevent something negative from happening and help other people."

– Glen Medcalf, Vancouver

Just before Thanksgiving in 2023, Glen Medcalf’s wife, Lorrie, woke up to him thrashing in bed. “She told me that we needed to go to the hospital,” recalls Medcalf. “That’s the last thing that I remember.”

Glen Medcalf and his wife, Lorrie, in the hospital.

Medcalf was taken by ambulance to the emergency department. His vital signs were in the extremes and his throat was swelling up. Doctors, including attending emergency physician Dr. Corinne Hohl, a Vancouver Coastal Health Research Institute researcher, were fighting to save Medcalf’s life.  

“At one point, he stopped breathing,” remembers Hohl. “His pH was 6.67, which was the lowest that I had ever seen in a patient.” A healthy pH level of blood and other fluids is between 7.35 and 7.45, with anything above or below requiring immediate emergency medical attention.

“Given what we were seeing, I suspected that he was likely experiencing an adverse drug event (ADE) caused by one of the medications he was taking,” says Hohl. 

After waking up from a coma, Medcalf recalls noticing the feeding tube in his throat and feeling weak and disoriented. “Lorrie was very worried about me,” he recalls. “A family friend told me that she had been a pile of jelly on the floor when I was in the emergency department.”

“Over two million Canadians visit an emergency department every year due to adverse drug events.”

An ADE is an unintended and harmful occurrence associated with one or more medications. Repeat ADEs are when a medication that previously caused harm is mistakenly re-prescribed. This most commonly happens when a care team is not aware about a prior ADE because they are not connected to information about a patient’s ADE history. 

Medcalf, who also lives with type 2 diabetes and high blood pressure, was managing his conditions with several medications, including Metformin, a common treatment for diabetes. However, in Medcalf, the medication caused a life-threatening adverse event called Metformin-induced lactic acidosis.

“Adverse drug events contribute to or cause one out of every nine patient admissions to the emergency department. One out of every three adverse drug events presenting to the emergency department is the result of a patient being re-prescribed the same medication.”

Hohl and her team created ActionADE to reduce unintentional re-exposures to previously harmful medications. The electronic platform can communicate information to community and hospital pharmacies across health sectors using the provincial PharmaNet network already in place at these facilities. Currently part of a randomized controlled trial, the goal of ActionADE is to increase patient safety, states Hohl.

Dr. Corinne Hohl practises emergency medicine at Vancouver General Hospital. She is a scientist at the Centre for Clinical Epidemiology and Evaluation, and professor and head of the Department of Emergency Medicine at the University of British Columbia.

“We do not want health providers to operate in silos, tracking ADEs only in their offices or at individual hospitals,” states Hohl. “We need a centralized database that offers an integrated ADE warning system that can prevent health providers from unknowingly re-exposing patients when re-exposure is not clinically indicated. ActionADE offers this solution.”

Prior to his 2023 hospitalization, Medcalf was admitted to hospital once in 2020 and again in 2021 for an ADE to the same culprit medication. Although less severe than what he would later experience in 2023, Medcalf’s broader care team did not receive or see the information about his ADE or its cause, resulting in him being re-prescribed the medication despite its harmful effects.

Watch Glen Medcalf share his ADE experience in this video:

Now in good spirits and health, Medcalf sits on the ActionADE research team as a patient partner. By sharing his story, Medcalf hopes to facilitate changes to the medical system that can help prevent future ADEs and patient harm. 

“Everyone in the ActionADE group has something to contribute,” says Medcalf. “As a patient partner, I am there to share my experience and help the research team arrive at solutions.” 

Learn more about Dr. Corinne Hohl’s research and ActionADE here.
 

This is one patient's story of participating in a research study. Your experience may differ. Learn about clinical trials before participating.

Researchers

Corinne Hohl

Related Articles

Gambling’s dopamine pathway to addiction

Looking FashionABLE in a wheelchair

Freeing Parkinson’s patients from depressive symptoms

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Emergency Medicine Research Program

Centre for Clinical Epidemiology and Evaluation

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy